Dose-limiting myelosuppression associated with high-dose cisplatin (200 mg/m2) in hypertonic saline.
D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy
D002945:Cisplatin